Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China

作者：Yongchen Hao, Dong Zhao, Jing Liu, Jun Liu, Na Yang, Yong Huo, Gregg C. Fonarow, Junbo Ge, Louise Morgan, Changsheng Ma, Yaling Han, Sidney C. Smith, CCC-ACS Investigators, Mingcheng Bai, Cui Bin, Dongsheng Chai, Rong Chang, Jiyan Chen, Moshui Chen, Guoxiong Chen, Kaihong Chen, Kaiming Chen, Manhua Chen, Xiaoping Chen, Ximing Chen, Ping Chen, Xia Chen, Guoduo Chen, Jie Chen, Xiufeng Chen, Shengyong Chen, Xiaoshu Cheng, Huimin Chu, Honghua Deng, Junping Deng, Jinglan Diao, Jiawang Ding, Pingshuan Dong, Hui Dong, Tianmin Du, Juexin Fan, Weiqing Fan, Junping Fang, Xiaoyun Feng, Guosheng Fu, Xianghua Fu, Fudong Gan, Chuanyu Gao, Junbo Ge, Jun Guan, Ying Guo, Yansong Guo, Haiping Guo, Guangshu Han, Minghua Han, Yaling Han, Yinglu Hao, Shenghu He, Zhaofa He, Zeyuan He, Yuqing Hou, Ping Hou, Jing Hu, Lan Huang, Weijian Huang, Yixiang Huang, Fangfang Huang, Yuehua Huang, Zhenguo Ji, Ji Lang, Zheng Ji, Shaobin Jia, Nan Jia, Jie Jiang, Li Jiang, Weihong Jiang, Hong Jiang, Yuan Jin, Chunlin Lai, Meisheng Lai, Bao Li, Bin Li, Guoqing Li, Hongwei Li, Jianhao Li, Junxia Li, Lang Li, Ling Li, Tianchang Li, Yongdong Li, Aihua Li, Jifu Li, Shuangbin Li, Xue Li, Zhanquan Li, Yong Li, Xiaolei Li, Dongyan Li, Songbai Li, Guo Li, Yue Li, Xudong Li, Fengwei Li, Xiaolan Li, Naiyi Liang, Chuanliang Liang, Wenhua Lin, Yingzhong Lin, Hailong Lin, Rong Lin, Haiyun Lin, Bin Liu, Jun‐Ming Liu, Xiaohui Liu, Weijun Liu, Yin Liu, Hualing Liu, Hui Liu, Jianwen Liu, Xuebo Liu, Changyong Liu, Wei Liu, Hong Liu, Hong Luan, Suxin Luo, Caidong Luo, Kalan Luo, Yingchao Luo, Genshan Ma, Shixin Ma, Shuren Ma, Yi-Tong Ma, Shaolin Mao, Xiaochuan Ma, Xiaowen Ma, Wei Mao, Lijun Meng, Fanju Meng, Shaoping Nie, Yanbo Niu, Zhihong Ou, Zewei Ouyang, Daoquan Peng, Xuemei Peng, Xiaowei Peng, Xiaoyong Qi, Peng Qu, Shuqiu Qu, Gengsheng Sang, Yuhuan Shi, Zhiyuan Song, Jin Su, Xi Su, Zhenqi Su, Qinfeng Su, Yong-long Su, Yuemin Sun, Xiaofei Sun, Yingxian Sun, Fakuan Tang, Jiong Tang, Lilong Tang, Xingsheng Tang, Xin Tang, Guizhou Tao, Ling Tao, Jianhong Tao, Miao Tian, Wei Tuo, Tian Tuo, Changqian Wang, Honhju Wang, Huifeng Wang, Jingfeng Wang, Zhirong Wang, Ningfu Wang, Wei Wang, Yan Wang, Yanggan Wang, Bin Wang, Siding Wang, Xiaojun Wang, Wang Lin, Chuntong Wang, Yanli Wang, Qichun Wang, Zhongshan Wang, Jinru Wei, Wei Lin, Wei Li, Di Wu, Lirong Wu, Chunyang Wu, Keng Wu, Qiang Wu, Tong-guo Wu, Jiabin Xi, Shudong Xia, Jun Xiao, Ping Xie, Qiang Xie, Shuanli Xin, Guoqin Xin, Biao Xu, Xu Dawen, Gang Xu, Weiting Xu, Zesheng Xu, Jing Xu, Jinchuan Yan, Zhenyu Yang, Zhijian Yang, Zhiming Yang, Bosong Yang, Tianlun Yang, Xiangjun Yang, Yanzong Yang, JiaoMei Yang, Jian Yang, Yuheng Yang, Jie Yang, Xiaoli Yang, Liqiong Yang, Jianfeng Ye, Shaowu Ye, Jinxing Yi, Jiyan Yin, Bo Yu, Yang Yu, Zuyi Yuan, Zheng Zhang, Chunyan Zhang, Guixia Zhang, Hong Zhang, Man Zhang, Peiying Zhang, Ping Zhang, Yonglin Zhang, Xianan Zhang, Huifang Zhang, Xiaoqin Zhang, Pengfei Zhang, Congliang Zhang, Shu‐Hua Zhang, Tao Zhang, Xianxian Zhao, Xingsheng Zhao, Yulan Zhao, Fang Zhao, Jingshan Zhao, Ruiping Zhao, Zheng Yang, Zeqi Zheng, Yanlie Zheng, Qiaoqing Zhong, Yuhua Zhu, Dongmei Zhu · 发表于：JAMA Cardiology · 年份：2022 · DOI：10.1001/jamacardio.2022.0117 · 被引用次数：32 · 研究领域：Acute Myocardial Infarction Research、Mechanical Circulatory Support Devices、Sepsis Diagnosis and Treatment

Importance: Despite advances in the treatment of ST-segment elevation myocardial infarction (STEMI), little is known about how this evolving knowledge is applied in current clinical practice in China. Objective: To evaluate hospital performance and temporal trends in the management of STEMI. Design, Setting, and Participants: This study used data from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project, a nationwide quality improvement registry, in collaboration with the American Heart Association and the Chinese Society of Cardiology. Participants included patients with STEMI admitted to 143 tertiary hospitals across China from November 2014 to July 2019, and data were analyzed from November 2020 to December 2021. Main Outcomes and Measures: Levels, hospital-level variations, and trends for utilization rates of the 9 management strategies with Class I recommendations in Chinese and US guidelines. Results: A total of 57 560 hospitalizations with STEMI were included. Overall, 20.0% of patients received all the care according to the 9 guideline-recommended strategies. The performance rate of quality measures was low for reperfusion therapy (61.0%, 35 115/57 560 patients), β-blocker at discharge (68.3%, 37 750/55 285 patients), angiotensin-converting enzyme inhibitor or angiotensin receptor blocker at discharge (55.1%, 2524/4578 patients), and smoking cessation counseling (36.5%, 9586/26 265 patients) among those who were eligible. Of 25 563 pa...